Palforzia Peanut Allergy Immunotherapy: Aimmune CEO On REMS Restrictions, Manufacturing

 
• By Brenda Sandburg
Peanut allergy.
Palforzia peanut allergy immunotherpay launch involves new challenges

More from Drug Safety

More from Pink Sheet